Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Advanced Breast Cancer
Related studies linked through entity extraction aliases.
A Phase Ib Study of Selatinib Ditosilate Tablets in Patients With Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Feasibility of a Team Approach for Discussing Prognosis and Treatment Goals in Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Developing Plasma DNA as a Surrogate for Tumor Biopsy to Identify Tumor Genetic Alterations in Patients With Advanced Breast Cancer
- Status
- TERMINATED
- Phase
- N/A
The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- N/A
A Clinical Trial to Study the Effects of Nanoparticle Based Paclitaxel Drug, Which Does Not Contain the Solvent Cremophor, in Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Level of HER2-neu Gene Amplification an Response to Trastuzumab
- Status
- UNKNOWN
- Phase
- N/A
Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor
- Status
- COMPLETED
- Phase
- PHASE2
HDAC Inhibitor Vorinostat (SAHA) With Capecitabine (Xeloda) Using a New Weekly Dose Regimen for Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Randomised,Multi-Center Study of Docetaxol Plus Capecitabine or Cisplatin in Anthracycline-Pretreated Patients With Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Second Line Breast Cancer Trial
- Status
- COMPLETED
- Phase
- PHASE3
Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Maintenance Versus Observation After 6 Cycles of Gemcitabine Plus Paclitaxel in Pts With Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Dasatinib Study in Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-line Therapy in HER2/Neu-positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
E3 Breast Cancer Taxotere Combination
- Status
- COMPLETED
- Phase
- PHASE2
AZD2171 in Addition to Fulvestrant in Patients With Advanced Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE2